Cargando…

Resistance to EGFR inhibitors: Molecular determinants and the enigma of head and neck cancer

Detalles Bibliográficos
Autores principales:	Morris, Luc G.T., Chan, Timothy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2011
Materias:	Editorial Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282094/ https://www.ncbi.nlm.nih.gov/pubmed/22248868

Ejemplares similares

COVID-19 and the Swedish enigma
por: Claeson, Mariam, et al.
Publicado: (2021)

Comment: Head and Neck Oncology
Publicado: (2014)

MERS-CoV in Africa—an enigma with relevance to COVID-19
por: Perlman, Stanley, et al.
Publicado: (2021)

Unraveling the molecular genetics of head and neck cancer through genome-wide approaches
por: Riaz, Nadeem, et al.
Publicado: (2014)

Expert consensus on the clinical application of recombinant adenovirus human p53 for head and neck cancers
por: Li, Yi, et al.
Publicado: (2021)

Genetics and Molecular Biology of Head and Neck Cancer
por: Szyfter, Krzysztof
Publicado: (2021)

What's New in Emergencies, Trauma, and Shock: Head Injury in Anticoagulated Patients – An Enigma
por: Chauhan, Vivek
Publicado: (2021)

EGFR in head and neck squamous cell carcinoma: exploring possibilities of novel drug combinations
por: Rehmani, Hina S., et al.
Publicado: (2020)

Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
por: Baba, Yuh, et al.
Publicado: (2012)

Comments on the Publication by Corkum et al on “Does 5 + 5 mm Equal Better Radiation Treatment Plans in Head and Neck Cancers?”
por: Grégoire, Vincent, et al.
Publicado: (2020)

The burnout enigma solved?
por: Schaufeli, Wilmar
Publicado: (2021)

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma
por: Vaquero, Javier, et al.
Publicado: (2018)

The FAT epidemic: A gene family frequently mutated across multiple human cancer types
por: Morris, Luc G.T., et al.
Publicado: (2013)

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib
por: Malapelle, Umberto, et al.
Publicado: (2022)

Head and Neck Cancer
por: Psyrri, Amanda, et al.
Publicado: (2009)

EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer
por: Cserepes, Mihály, et al.
Publicado: (2022)

Targeting the tyrosine kinase inhibitor-resistant mutant EGFR pathway in lung cancer without targeting EGFR?
por: De Greve, Jacques, et al.
Publicado: (2020)

Tuberculosis and sarcoidosis: The continuing enigma
por: Gupta, Dheeraj
Publicado: (2009)

Enigma of cerebrospinal fluid dynamics
por: Klarica, Marijan, et al.
Publicado: (2014)

Postmenopausal endometriosis: An enigma revisited
por: Shah, Duru
Publicado: (2014)

The Enigma of Sphingolipids in Health and Disease
por: Kleuser, Burkhard
Publicado: (2018)

Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
por: Francica, Paola, et al.
Publicado: (2018)

Aurora kinases shed light on resistance to EGFR inhibition in head and neck cancer
por: Kim, Donghwa, et al.
Publicado: (2021)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma
por: Valero, Cristina, et al.
Publicado: (2023)

The Density Factor: The Enigma of Dense Breast
por: Padhy, Ajit Kumar, et al.
Publicado: (2012)

Diagnostic enigmas of retinopathy: New dimensions
por: Natarajan, Sundaram
Publicado: (2014)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

Bosutinib Inhibits EGFR Activation in Head and Neck Cancer
por: Segrelles, Carmen, et al.
Publicado: (2018)

Head and Neck Pathology: New Developments in the Diagnosis and Pathogenesis of Head and Neck Tumors
por: Pambuccian, Stefan E., et al.
Publicado: (2011)

Breathing down the neck of Unc104
por: Wordeman, Linda
Publicado: (2003)

Speech therapy in head and neck cancer
por: Rossi, Vaneli Colombo, et al.
Publicado: (2021)

Human molecular genetics sheds light on the physiological significance of ribonuclease inhibitor (RNH1)
por: Sarangdhar, Mayuresh Anant, et al.
Publicado: (2023)

Foreword: varicocele – unraveling the enigma
por: Thomas, Anthony J
Publicado: (2016)

The enigma of demonetization and the unexplored consequences
por: Enara, Arun, et al.
Publicado: (2018)

Co-selected mutations in VCP: a novel mechanism of resistance to VCP inhibitors
por: Bastola, Prabhakar, et al.
Publicado: (2018)

The enigma that is the nucleus pulposus cell: the search goes on
por: Erwin, W Mark
Publicado: (2010)

Airway disease: a confusion inside an enigma
por: Morice, Alyn H.
Publicado: (2022)

The Enigma of Atypical Cartilaginous Tumors: Surgery or Surveillance?
por: Leithner, Andreas, et al.
Publicado: (2023)

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs
por: Abassi, Zaid, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dhgv41og4u34rmfmb5ckg07b02